Hernández F, Castellanos G, Valenzuela C, Catasús K, Valle R, Aguilera A. Recombinant streptokinase vs phenylephrine-based suppositories in acute hemorrhoids, randomized, controlled trial (THERESA-3). World J Gastroenterol 2014 February 14; 20(6):1594-1601
Alfonso S, Valdés-Zayas A, Santiesteban ER, Flores YI, Areces F, Hernández M, Viada CE, Mendoza IC, Guerra PP, García E. Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients. Clin Cancer Res 2014 July 15; 20(14): 3660-71
Viada C, Dupuy JF, Fors M, Lorenzo P. Stratified Cox Regression Analysis of Survival under CIMAvax®EGF Vaccine. Journal of Cancer Therapy, 2013 (4) 8-14
Robaina M, Uranga R, Fors M, Viada C. Algunas consideraciones para abordar mejor los datos incompletos en ensayos clínico. ICB digital/ Medicina Clínica Barcelona. diciembre 2012-enero (81): 2-10
Yera I, Alonso L, Valenzuela C. Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers. BMC Pharmacology and Toxicology 2013;14:44
Viada C, Ballesteros J, Fors M, Luaces P, Sánchez L. Crombet T. PCN168-A Proposed 6-Item Reduction for the European Organization for the Research and Treatment of Cancer-Quality of Core Questionnaire (EORTC QLQ-C30)-Cuban +Group of Trialists on Epidermal Growth Factor (CGT-EGF). Value in Health 2013;16 ( 7): A422
Fors M, Dupuy J, Viada C. Effectiveness of adaptive designs for phase II cancer trials. Contem. Clin. Trials. 2012 Ene; 33 (1): 223-7.
Luaces P, Lazo NG, Soriano JL, Gonzalez CE, Hernadez IM, Albuerne YÁ, Moreno BP, Alvarez ES, Callejo IP, Alert J, Martell JA, Gonzalez YS, Gonzalez YS, Astudillo de la Vega H, Ruiz-Garcia EB, Ramos TC. Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy. Cancer Biol Ther. 2012 Jun;13(8):600-5
Torre A, Hernández J, Ortiz R, Cepeda M, Pérez K, Car A, Viada C, Toledo D, Guerra PP, García E, et al. NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial. Breast Cancer 2012:6 151–157
